CTCF and metabolic dysfunction-associated steatotic liver disease: The RT-PCR analysis indicated that the mRNA levels of CTCF, DPP4, NLRP3 and ASC were increased in the NAFLD model mice but decreased by gardenoside and si-CTCF treatments (Figures 9L–O).